These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9615811

  • 21. Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension.
    Lissoni P, Brivio F, Barni S, Tancini G, Cattaneo G, Archili C, Conti A, Maestroni GJ.
    Anticancer Res; 1990; 10(6):1759-61. PubMed ID: 2285255
    [Abstract] [Full Text] [Related]

  • 22. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent.
    Lissoni P.
    Pathol Biol (Paris); 2007; 55(3-4):198-200. PubMed ID: 17451889
    [Abstract] [Full Text] [Related]

  • 23. A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.
    Lissoni P, Vaghi M, Ardizzoia A, Malugani F, Fumagalli E, Bordin V, Fumagalli L, Bordoni A, Mengo S, Gardani GS, Tancini G.
    In Vivo; 2002; 16(2):93-6. PubMed ID: 12073777
    [Abstract] [Full Text] [Related]

  • 24. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
    Spolarics Z, Siddiqi M, Siegel JH, Garcia ZC, Stein DS, Denny T, Deitch EA.
    Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.
    Muc-Wierzgon M, Nowakowska-Zajdel E, Zubelewicz B, Wierzgon J, Kokot T, Klakla K, Szkilnik R, Wiczkowski A.
    J Exp Clin Cancer Res; 2003 Jun; 22(2):171-8. PubMed ID: 12866566
    [Abstract] [Full Text] [Related]

  • 28. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency.
    Klínger J, Enríquez J, Arturo JA, Delgado M, Avila G, Ceballos O.
    Adv Perit Dial; 2002 Jun; 18():170-6. PubMed ID: 12402613
    [Abstract] [Full Text] [Related]

  • 29. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
    Moriconi F, Raddatz D, Ho NA, Yeruva S, Dudas J, Ramadori G.
    Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
    [Abstract] [Full Text] [Related]

  • 30. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y.
    Anticancer Res; 2006 Oct; 26(2A):1113-34. PubMed ID: 16619514
    [Abstract] [Full Text] [Related]

  • 31. A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients.
    Lissoni P, Rovelli F, Brivio F, Fumagalli L, Brera G.
    In Vivo; 2008 Oct; 22(3):397-400. PubMed ID: 18610754
    [Abstract] [Full Text] [Related]

  • 32. Alterations of pineal gland and of T lymphocyte subsets in metastatic cancer patients: preliminary results.
    Lissoni P, Tancini G, Barni S, Viviani S, Archili C, Cattaneo G, Fiorelli G.
    J Biol Regul Homeost Agents; 1989 Oct; 3(4):181-3. PubMed ID: 2534688
    [Abstract] [Full Text] [Related]

  • 33. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
    Alvarado Esquivel C, Elewaut A, Philippé J, Elewaut AE, Desombere I, Maertens G, Leroux-Roels G.
    Rev Invest Clin; 2002 Oct; 54(1):41-50. PubMed ID: 11995406
    [Abstract] [Full Text] [Related]

  • 34. Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia.
    Lissoni P, Brivio F, Fumagalli L, Messina G, Secreto G, Romelli B, Fumagalli G, Rovelli F, Colciago M, Brera G.
    In Vivo; 2007 Oct; 21(4):647-50. PubMed ID: 17708360
    [Abstract] [Full Text] [Related]

  • 35. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L, Dusek L, Simícková M, Rovný F, Spurný V, Rovný A, Slampa P, Zaloudík J, Rejthar A, Wotke J, Kovarík J.
    Neoplasma; 1999 Oct; 46(3):141-9. PubMed ID: 10613588
    [Abstract] [Full Text] [Related]

  • 36. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb.
    Madej A, Okopien B, Kowalski J, Zielinski M, Wysocki J, Szygula B, Kalina Z, Herman ZS.
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):345-9. PubMed ID: 9660044
    [Abstract] [Full Text] [Related]

  • 37. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F, Di Marco R, Patti F, Zaccone P, L'Episcopo MR, Reggio E, Xiang M, Nicoletti A, Reggio A.
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
    Krampera M, Tavecchia L, Benedetti F, Nadali G, Pizzolo G.
    Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.